ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

ClinicalTrials.gov ID: NCT02163993

Public ClinicalTrials.gov record NCT02163993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 3, 2026, 1:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine

Study identification

NCT ID
NCT02163993
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
414 participants

Conditions and interventions

Interventions

  • Galcanezumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2014
Primary completion
Aug 18, 2015
Completion
Feb 11, 2018
Last update posted
Nov 22, 2018

2014 – 2018

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
Clinical Research Advantage Gilbert Arizona 85234
21st Century Neurology Phoenix Arizona 85004
Arizona Research Center Phoenix Arizona 85023
Pharmacology Research Institute, Long Beach Encino California 91316
Collaborative Neuroscience Network - CNS Long Beach California 90806
Pharmacology Research Institute, Long Beach Los Alamitos California 90720
Pharmacology Research Institute, Long Beach Newport Beach California 92660
Desert Valley Research Rancho Mirage California 92270
Artemis Institute for Clinical Research San Diego California 92013
Medical Center for Clinical Research San Diego California 92108
San Francisco Clinical Research Center San Francisco California 94109
California Medical Clinic for Headache Santa Monica California 90404
Alpine Clinical Research Center Boulder Colorado 80304
New England Institute for Clinical Research Stamford Connecticut 06905
Avail Clinical Research LLC DeLand Florida 32720
Florida Clinical Research Center LLC Maitland Florida 32751
Renstar Medical Research Ocala Florida 34471
Psychiatric Inst of Florida-Clinical Neuroscience Solutions Orlando Florida 32801
Premiere Research Institute at Palm Beach Neurology West Palm Beach Florida 33407
Otri-Med Corporation Edgewood Kentucky 41017
PharmaSite Research Inc Baltimore Maryland 21208
Boston Clinical Trials Inc Boston Massachusetts 02131
Michigan Head, Pain and Neurological Institute Ann Arbor Michigan 48104
Westside Family Medical Center Kalamazoo Michigan 49009
ClinVest Springfield Missouri 68507
Mercy Health Research St Louis Missouri 63141
Albuquerque Clinical Trials Albuquerque New Mexico 87102
Island Neuro Associates,PC Plainview New York 11803
Rochester Clinical Research, Inc. Rochester New York 14609
PharmQuest Greensboro North Carolina 27408
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103
Summit Research Network Inc Portland Oregon 97210
Thomas Jefferson University Philadelphia Pennsylvania 19107
Coastal Carolina Research Center, Inc. Mt. Pleasant South Carolina 29464
CNS Health Care Memphis Tennessee 38119
FutureSearch Trials Austin Texas 78731
DermResearch Austin Texas 78759
Northwest Clinical Research Center Bellevue Washington 98007
North Seattle Womens Group Seattle Washington 98105
Dean Foundation for Health Research and Education Middleton Wisconsin 53562

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02163993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2018 · Synced May 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02163993 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →